Standout Papers

Bosutinib Versus Imatinib for Newly Diagnosed Chronic ... 2010 2026 2015 2020 1.1k
  1. Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial (2017)
    Jörge E. Cortes, Carlo Gambacorti‐Passerini et al. Journal of Clinical Oncology
  2. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (2010)
    Hagop M. Kantarjian, Neil P. Shah et al. New England Journal of Medicine
  3. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial (2016)
    Jörge E. Cortes, Giuseppe Saglio et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 22 from Science/Nature 67 standout
Sub-graph 1 of 20

Citing Papers

Acquisition of epithelial plasticity in human chronic liver disease
2024 StandoutNature
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
2024 StandoutNature
2 intermediate papers

Works of Charles Chuah being referenced

Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia
2014
Regulation of myeloid leukaemia by the cell-fate determinant Musashi
2010 Nature

Author Peers

Author Last Decade Papers Cites
Charles Chuah 3405 2621 1035 1554 107 4.5k
Philipp le Coutre 3452 2631 850 1737 153 4.7k
Thomas O’Hare 3698 2879 1601 1673 116 5.5k
Zbigniew Rudzki 2650 2185 695 1523 101 3.7k
Laurence Legros 3531 2662 703 1492 126 4.0k
Michael J. Mauro 3817 2964 798 2059 230 5.1k
Nicoletta Testoni 3614 1840 1472 983 183 4.3k
Deborah L. White 3165 2098 869 1062 155 4.4k
Gabriel Étienne 5151 4198 736 2425 108 6.0k
Ronald Paquette 3179 2321 1509 1096 117 4.9k
H. Kantarjian 2398 2075 970 764 117 3.8k

All Works

Loading papers...

Rankless by CCL
2026